Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single vs Multi-Dose Oral Tranexamic Acid in High-Risk Total Joint Arthroplasty
NCT02926651Phase 4Withdrawn
- Sponsor
- Rush University Medical Center
- Start
- Oct 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in postoperative hemorrhage, sponsored by Rush University Medical Center. Planned start Oct 2016; status: withdrawn.
02
Drugs
tranexamic acid
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT02926651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02926651.